Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

    Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci
    e2024041
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.041
    1386
    PDF: 1141
    Suppl. Files: 756
    HTML: 100
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    2077
    PDF: 1275
    HTML: 359
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2819
    PDF: 974
    HTML: 2150
  • A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients

    Kanchan Mishra, Avani Shah, Krima Patel, Kanjaksha Ghosh, Sumit Bharadva
    e2020038
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.038
    1595
    PDF: 842
    HTML: 594
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    8030
    PDF: 2548
    HTML: 2185
    Table 1.: 292
    Table 2.: 318
    Table 3.: 277
    Table 4.: 282
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4531
    PDF: 1490
    HTML: 2219
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    e2026022
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1992
    PDF: 2196
    Suppl. Files: 304
    HTML: 129
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1602
    PDF: 829
    HTML: 517
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4285
    PDF: 1372
    HTML: 2136
    Table 1: 260
  • First-Line Flumatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A 3-Month Landmark-Evaluable Real-World Experience

    Dangui Chen
    e2026066
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.066
    189
    PDF: 102
    Html: 71
  • THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.

    Sanaa Kamal, Sara Abdelhakam, Dr., Dahlia Ghoraba, Mohamad Amer Mohsen, Ahmed Abdelsalam, Huda Hassan, Leila Nabeigh
    e2019060
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.060
    1652
    PDF: 1160
    HTML: 243
  • HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

    Armando Tripodi
    e2024027
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.027
    1179
    PDF: 1484
    HTML: 222
  • DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

    Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes
    e2020016
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.016
    2114
    PDF: 1190
    HTML: 459
  • DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

    alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini
    e2019044
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.044
    2105
    PDF: 1603
    HTML: 508
  • MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA

    Alessandro Granito, Luigi Bolondi
    e2009021
    https://doi.org/10.4084/mjhid.2009.021
    811
    PDF: 517
    HTML: 6300
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4533
    PDF: 1565
    HTML: 818
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    4023
    PDF: 1182
    HTML: 2597
  • Severe Acute Hepatitis B Treated with Entecavir

    Giuseppe Vittorio Luigi De Socio, Alessio Sgrelli, Andrea Tosti, Franco Baldelli
    e2011010
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.010
    1774
    PDF: 953
    HTML: 2576
    Figure: 228
    Title page: 234
    disclosure: 154
  • ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS

    saveria capria, silvia maria trisolini, clara minotti, caterina stefanizzi, luisa cardarelli, Martina Canichella, claudio cartoni, daniela diverio, maria stefania de propris, marco mancini, alessandra micozzi, robin foà, giovanna meloni
    e2012072
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.072
    1820
    PDF: 908
    HTML: 977
    cover letter: 393
  • MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS

    Lucio Amitrano, Maria Anna Guardascione
    e2009014
    https://doi.org/10.4084/mjhid.2009.014
    902
    PDF: 609
    HTML: 4058
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1743
    PDF: 1002
    HTML: 419
  • LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE

    Patrizia Tosi
    e2013037
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.037
    1507
    PDF: 998
    HTML: 1312
    fig 1A: 254
    figure1B: 220
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2563
    PDF: 1994
    HTML: 203
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    3057
    PDF: 1062
    HTML: 675
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    6635
    PDF: 2536
    HTML: 1595
  • IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

    Tomasz Sacha
    e2014007
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.007
    5270
    PDF: 3051
    HTML: 2390
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3614
    PDF: 1788
    HTML: 1854
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2270
    PDF: 1158
    HTML: 1276
  • CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone
    e2013031
    2013-05-01
    https://doi.org/10.4084/mjhid.2013.031
    3535
    PDF: 1002
    HTML: 1565
    Fig.1 CHL-R paper: 285
    Fig 2 CHL-R paper: 323
  • Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia

    Tuba Gullu koca, Ahmet Mert Yanik
    e2026069
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.069
    205
    PDF: 158
    Html: 37
  • Ixazomib-associated skin exfoliation

    Yali Zhang, Long Zhao, Yuancheng Guo, bei liu
    e2022045
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.045
    1024
    PDF: 653
    HTML: 269
  • Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.

    Giuseppe Vittorio De Socio, Gianluigi Fabbriciani, Marco Massarotti, Salvatore Messina, Enisia Cecchini, Bianca Marasini
    e2012025
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.025
    1559
    PDF: 975
    HTML: 10136
    cover letter to the editor: 229
    tile page: 311
  • PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

    Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel
    e2020072
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.072
    1388
    PDF: 883
    HTML: 434
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1351
    PDF: 601
    HTML: 1730
    Figures: 226
    Fifures Sanz: 234
    tables Sanz: 239
    Untitled: 230
  • INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

    Livio Pagano, Davide Facchinelli, Dr.
    e2018063
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.063
    2235
    PDF: 1211
    HTML: 376
  • A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

    Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani
    e2012017
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.017
    1432
    PDF: 723
    HTML: 827
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1241
    PDF: 519
    HTML: 373
  • THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

    Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
    e2016025
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.025
    6601
    PDF: 2290
    HTML: 14187
    Untitled: 273
    figure: 245
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2881
    PDF: 2239
    HTML: 954
  • FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

    Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter
    e2023041
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.041
    1805
    PDF: 825
    HTML: 260
  • ANTIBIOTIC LOCK THERAPY FOR PORT CATHETER-RELATED INFECTIONS OF CHILDREN WITH ACUTE LEUKEMIA

    Burçin Kurtipek; Ayça Koca Yozgat, Saliha Kanık Yüksek, Dilek Kaçar, Turan Bayhan, Dilek Gürlek Gökçebay, Aslınur Özkaya Parlak, Neşe Yaralı
    e2024072
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.072
    2430
    PDF: 1202
    HTML: 473
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    4068
    PDF: 1413
    HTML: 989
    Figure 2: 535
    Figure 1: 3224
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

    Monica Carpenedo, Dr, Dr, Dr
    e2023021
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.021
    1387
    PDF: 1254
    HTML: 757
  • Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia

    Alhossain A. Khalafallah, Zafreen Rahman, Kath Ogden, Terry Hannan
    e2012003
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.003
    1665
    PDF: 938
    HTML: 1136
    Untitled: 237
  • Management of pediatric rheumatological diseases during the outbreak of COVID-19: our experience

    Romina Gallizzi, Diana Sutera, Francesca Mazza, Alessandra Spagnolo, Giovanni Battista Pajno
    e2020049
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.049
    1243
    PDF: 822
    HTML: 252
  • OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA

    Adriano Venditti, Marta Riva, Livio Pagano, Giovanni Marconi, Nicola Fracchiolla, Romano Danesi, Antonio Curti, Anna Candoni, Erika Borlenghi, Maria Teresa Voso
    e2026086
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.086
    158
    PDF: 98
    Html: 29
  • MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE

    Claudia Gomez-Hernandez, Carmen Corrales, Pedro José Mirete, Soraya Ramos, Mireia Micó-Cerdà, Clara Martinez-Lopez, Juan Carlos Hernandez-Boluda, Carlos Solano, Rafael de la Camara, Jose Luis Piñana
    e2026072
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.072
    225
    PDF: 258
    Suppl. Files: 51
    Html: 123
    Html Suppl. Files: 110
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    3126
    PDF: 1487
    HTML: 3750
    Untitled: 284
    Untitled: 280
    Untitled: 231
  • DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura

    Yi Liu, Fan Lu, Binbin Ji, Wei Song, Hui Shen, Yingjie Xu, bining Yang
    e2026019
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.019
    998
    PDF: 858
    HTML: 259
  • GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

    Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN
    e2023031
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.031
    1690
    PDF: 1006
    Suppl. Files: 505
    HTML: 316
101 - 150 of 359 items << < 1 2 3 4 5 6 7 8 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.